Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity (Q40890211)

24 September 2017

title

Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity (English)

1 reference

24 September 2017

0 references

Teramoto N

1

1 reference

24 September 2017

Maeda A

2

1 reference

24 September 2017

Kobayashi K

3

1 reference

24 September 2017

Hayashi K

4

1 reference

24 September 2017

Oka T

5

1 reference

24 September 2017

Takahashi K

6

1 reference

24 September 2017

Takada K

7

1 reference

24 September 2017

Klein G

8

1 reference

24 September 2017

Akagi T

9

1 reference

24 September 2017

publication date

1 March 2000

1 reference

24 September 2017

published in

Laboratory Investigation

1 reference

24 September 2017

volume

80

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

303-312

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3780035

24 September 2017

exact match

0 references

cites work

Epstein-Barr virus strategy in normal and neoplastic B cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

Direct detection of Epstein-Barr virus DNA from a single Reed-Sternberg cell of Hodgkin's disease by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

The epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

7 January 2021

Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

7 January 2021

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

7 January 2021

Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

7 January 2021

Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780035

7 January 2021

10.1038/LABINVEST.3780035

Identifiers

DOI

1 reference

24 September 2017

1 reference